
Anna Pagonakis
Examiner (ID: 6985)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1614, 4173, 1609, 1628, OPET |
| Total Applications | 1238 |
| Issued Applications | 444 |
| Pending Applications | 73 |
| Abandoned Applications | 723 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5035317
[patent_doc_number] => 20070099856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Combined treatment with docetaxel and an epidermal growth factor receptor kinase inhibitor using an intermittent dosing regimen'
[patent_app_type] => utility
[patent_app_number] => 11/434533
[patent_app_country] => US
[patent_app_date] => 2006-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12559
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20070099856.pdf
[firstpage_image] =>[orig_patent_app_number] => 11434533
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/434533 | Combined treatment with docetaxel and an epidermal growth factor receptor kinase inhibitor using an intermittent dosing regimen | May 14, 2006 | Abandoned |
Array
(
[id] => 4698951
[patent_doc_number] => 20080221135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'COMBINATION THERAPY'
[patent_app_type] => utility
[patent_app_number] => 11/382737
[patent_app_country] => US
[patent_app_date] => 2006-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2744
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221135.pdf
[firstpage_image] =>[orig_patent_app_number] => 11382737
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/382737 | COMBINATION THERAPY | May 10, 2006 | Abandoned |
Array
(
[id] => 4814059
[patent_doc_number] => 20080194690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Pharmaceutical Formulations Of Hdac Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/913191
[patent_app_country] => US
[patent_app_date] => 2006-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20784
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194690.pdf
[firstpage_image] =>[orig_patent_app_number] => 11913191
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/913191 | Pharmaceutical formulations of HDAC inhibitors | May 10, 2006 | Issued |
Array
(
[id] => 4613226
[patent_doc_number] => 07989445
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-02
[patent_title] => 'Thienopyrimidone compound'
[patent_app_type] => utility
[patent_app_number] => 11/919301
[patent_app_country] => US
[patent_app_date] => 2006-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26639
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/989/07989445.pdf
[firstpage_image] =>[orig_patent_app_number] => 11919301
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919301 | Thienopyrimidone compound | Apr 26, 2006 | Issued |
Array
(
[id] => 5057731
[patent_doc_number] => 20070060653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Physiologic vaginal lubrication to optimize sperm survival and function'
[patent_app_type] => utility
[patent_app_number] => 11/407383
[patent_app_country] => US
[patent_app_date] => 2006-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4175
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20070060653.pdf
[firstpage_image] =>[orig_patent_app_number] => 11407383
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/407383 | Physiologic vaginal lubrication to optimize sperm survival and function | Apr 18, 2006 | Abandoned |
Array
(
[id] => 5480761
[patent_doc_number] => 20090203718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'CANCER TREATMENT METHOD'
[patent_app_type] => utility
[patent_app_number] => 12/296972
[patent_app_country] => US
[patent_app_date] => 2006-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14332
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12296972
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/296972 | CANCER TREATMENT METHOD | Apr 12, 2006 | Abandoned |
Array
(
[id] => 5661118
[patent_doc_number] => 20060251714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Pharmaceutical formulations of amyloid inhibiting compounds'
[patent_app_type] => utility
[patent_app_number] => 11/402267
[patent_app_country] => US
[patent_app_date] => 2006-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 41827
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20060251714.pdf
[firstpage_image] =>[orig_patent_app_number] => 11402267
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/402267 | Pharmaceutical formulations of amyloid inhibiting compounds | Apr 11, 2006 | Abandoned |
Array
(
[id] => 5858019
[patent_doc_number] => 20060228405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Phospholipid-based pharmaceutical formulations and methods for producing and using same'
[patent_app_type] => utility
[patent_app_number] => 11/279088
[patent_app_country] => US
[patent_app_date] => 2006-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12843
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20060228405.pdf
[firstpage_image] =>[orig_patent_app_number] => 11279088
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/279088 | Phospholipid-based pharmaceutical formulations and methods for producing and using same | Apr 6, 2006 | Abandoned |
Array
(
[id] => 4960646
[patent_doc_number] => 20080275071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Radiotherapy Enhancer'
[patent_app_type] => utility
[patent_app_number] => 11/910123
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6982
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20080275071.pdf
[firstpage_image] =>[orig_patent_app_number] => 11910123
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/910123 | Radiotherapy Enhancer | Mar 30, 2006 | Abandoned |
Array
(
[id] => 5051931
[patent_doc_number] => 20070032476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/390480
[patent_app_country] => US
[patent_app_date] => 2006-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9247
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20070032476.pdf
[firstpage_image] =>[orig_patent_app_number] => 11390480
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/390480 | Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof | Mar 27, 2006 | Issued |
Array
(
[id] => 8177272
[patent_doc_number] => 08178528
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-15
[patent_title] => 'Histamine H3 receptor agents, preparation and therapeutic uses'
[patent_app_type] => utility
[patent_app_number] => 11/909727
[patent_app_country] => US
[patent_app_date] => 2006-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15376
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/178/08178528.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909727
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909727 | Histamine H3 receptor agents, preparation and therapeutic uses | Mar 27, 2006 | Issued |
Array
(
[id] => 4887717
[patent_doc_number] => 20080262049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Therapeutic Agent for Hematopoietic Tumor'
[patent_app_type] => utility
[patent_app_number] => 11/909324
[patent_app_country] => US
[patent_app_date] => 2006-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26055
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20080262049.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909324
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909324 | Therapeutic Agent for Hematopoietic Tumor | Mar 21, 2006 | Abandoned |
Array
(
[id] => 4698936
[patent_doc_number] => 20080221120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'Modulation of Aquaporin in Modulation of Angiogenesis and Cell Migration'
[patent_app_type] => utility
[patent_app_number] => 11/908399
[patent_app_country] => US
[patent_app_date] => 2006-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 18350
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221120.pdf
[firstpage_image] =>[orig_patent_app_number] => 11908399
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908399 | Modulation of Aquaporin in Modulation of Angiogenesis and Cell Migration | Mar 20, 2006 | Abandoned |
Array
(
[id] => 5705792
[patent_doc_number] => 20060194840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Method for treating snoring and sleep apnea with leukotriene antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/385583
[patent_app_country] => US
[patent_app_date] => 2006-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10210
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194840.pdf
[firstpage_image] =>[orig_patent_app_number] => 11385583
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/385583 | Method for treating snoring and sleep apnea with leukotriene antagonists | Mar 19, 2006 | Abandoned |
Array
(
[id] => 5890206
[patent_doc_number] => 20060276534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Methods of decreasing calcification'
[patent_app_type] => utility
[patent_app_number] => 11/378879
[patent_app_country] => US
[patent_app_date] => 2006-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 11459
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20060276534.pdf
[firstpage_image] =>[orig_patent_app_number] => 11378879
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/378879 | Methods of decreasing calcification | Mar 16, 2006 | Abandoned |
Array
(
[id] => 5700752
[patent_doc_number] => 20060217437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'TGF-beta modulators and methods for using the same'
[patent_app_type] => utility
[patent_app_number] => 11/384113
[patent_app_country] => US
[patent_app_date] => 2006-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7878
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217437.pdf
[firstpage_image] =>[orig_patent_app_number] => 11384113
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/384113 | TGF-beta modulators and methods for using the same | Mar 16, 2006 | Abandoned |
Array
(
[id] => 5297125
[patent_doc_number] => 20090012051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'EXTERNAL PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 11/908232
[patent_app_country] => US
[patent_app_date] => 2006-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9463
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012051.pdf
[firstpage_image] =>[orig_patent_app_number] => 11908232
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908232 | EXTERNAL PREPARATION | Mar 14, 2006 | Abandoned |
Array
(
[id] => 4960577
[patent_doc_number] => 20080275002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Method for Treatment of Hepatic Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/817986
[patent_app_country] => US
[patent_app_date] => 2006-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3783
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20080275002.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817986
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817986 | Method for Treatment of Hepatic Cancer | Mar 6, 2006 | Abandoned |
Array
(
[id] => 5258699
[patent_doc_number] => 20070212331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Methods and compositions for selectively killing cells'
[patent_app_type] => utility
[patent_app_number] => 11/369786
[patent_app_country] => US
[patent_app_date] => 2006-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8213
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20070212331.pdf
[firstpage_image] =>[orig_patent_app_number] => 11369786
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/369786 | Methods and compositions for selectively killing cells | Mar 6, 2006 | Abandoned |
Array
(
[id] => 5700670
[patent_doc_number] => 20060217355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Co-administration of dehydroepiandrosterone (DHEA) congeners and other active agents for treating cancer'
[patent_app_type] => utility
[patent_app_number] => 11/370218
[patent_app_country] => US
[patent_app_date] => 2006-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8667
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217355.pdf
[firstpage_image] =>[orig_patent_app_number] => 11370218
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/370218 | Co-administration of dehydroepiandrosterone (DHEA) congeners and other active agents for treating cancer | Mar 5, 2006 | Abandoned |